147 related articles for article (PubMed ID: 18070963)
1. Tetracycline resistance gene tet(W) in the pathogenic bacterium Clostridium difficile.
Spigaglia P; Barbanti F; Mastrantonio P
Antimicrob Agents Chemother; 2008 Feb; 52(2):770-3. PubMed ID: 18070963
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of tet(W) gene-mediated tetracycline resistance in dominant intestinal Bifidobacterium species from healthy humans.
Flórez AB; Ammor MS; Alvarez-Martín P; Margolles A; Mayo B
Appl Environ Microbiol; 2006 Nov; 72(11):7377-9. PubMed ID: 16936047
[TBL] [Abstract][Full Text] [Related]
3. In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.
Carman RJ; Boone JH; Grover H; Wickham KN; Chen L
Antimicrob Agents Chemother; 2012 Nov; 56(11):6019-20. PubMed ID: 22908175
[TBL] [Abstract][Full Text] [Related]
4. New variants of the tet(M) gene in Clostridium difficile clinical isolates harbouring Tn916-like elements.
Spigaglia P; Barbanti F; Mastrantonio P
J Antimicrob Chemother; 2006 Jun; 57(6):1205-9. PubMed ID: 16565156
[TBL] [Abstract][Full Text] [Related]
5. Surface layer protein A variant of Clostridium difficile PCR-ribotype 027.
Spigaglia P; Barbanti F; Mastrantonio P
Emerg Infect Dis; 2011 Feb; 17(2):317-9. PubMed ID: 21291621
[No Abstract] [Full Text] [Related]
6. Genetic basis of tetracycline resistance in Bifidobacterium animalis subsp. lactis.
Gueimonde M; Flórez AB; van Hoek AH; Stuer-Lauridsen B; Strøman P; de los Reyes-Gavilán CG; Margolles A
Appl Environ Microbiol; 2010 May; 76(10):3364-9. PubMed ID: 20348299
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary analysis of a nontoxigenic Clostridium difficile strain with stable resistance to metronidazole.
Moura I; Monot M; Tani C; Spigaglia P; Barbanti F; Norais N; Dupuy B; Bouza E; Mastrantonio P
Antimicrob Agents Chemother; 2014 Aug; 58(8):4957-60. PubMed ID: 24913157
[TBL] [Abstract][Full Text] [Related]
8. Analysis of tetracycline resistance tet(W) genes and their flanking sequences in intestinal Bifidobacterium species.
Ammor MS; Flórez AB; Alvarez-Martín P; Margolles A; Mayo B
J Antimicrob Chemother; 2008 Oct; 62(4):688-93. PubMed ID: 18614524
[TBL] [Abstract][Full Text] [Related]
9. Paeniclostridium sordellii and Clostridioides difficile encode similar and clinically relevant tetracycline resistance loci in diverse genomic locations.
Vidor CJ; Bulach D; Awad M; Lyras D
BMC Microbiol; 2019 Mar; 19(1):53. PubMed ID: 30832583
[TBL] [Abstract][Full Text] [Related]
10. ErmB determinants and Tn916-Like elements in clinical isolates of Clostridium difficile.
Spigaglia P; Carucci V; Barbanti F; Mastrantonio P
Antimicrob Agents Chemother; 2005 Jun; 49(6):2550-3. PubMed ID: 15917571
[TBL] [Abstract][Full Text] [Related]
11. Widespread distribution of a tet W determinant among tetracycline-resistant isolates of the animal pathogen Arcanobacterium pyogenes.
Billington SJ; Songer JG; Jost BH
Antimicrob Agents Chemother; 2002 May; 46(5):1281-7. PubMed ID: 11959557
[TBL] [Abstract][Full Text] [Related]
12. In vivo selection of moxifloxacin-resistant Clostridium difficile.
Mena A; Riera E; López-Causapé C; Weber I; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2012 May; 56(5):2788-9. PubMed ID: 22371889
[No Abstract] [Full Text] [Related]
13. Tetracycline resistance mediated by tet(W), tet(M), and tet(O) genes of Bifidobacterium isolates from humans.
Aires J; Doucet-Populaire F; Butel MJ
Appl Environ Microbiol; 2007 Apr; 73(8):2751-4. PubMed ID: 17308188
[TBL] [Abstract][Full Text] [Related]
14. Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1.
Akerlund T; Persson I; Unemo M; Norén T; Svenungsson B; Wullt M; Burman LG
J Clin Microbiol; 2008 Apr; 46(4):1530-3. PubMed ID: 18287318
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a new Clostridium difficile ribotype during a prospective study in a hospital in Italy.
Sisto F; Maraschini A; Fabio G; Serafino S; Zago M; Scaltrito MM; Castaldi S
Curr Microbiol; 2015 Feb; 70(2):151-3. PubMed ID: 25240292
[No Abstract] [Full Text] [Related]
16. Tet 42, a novel tetracycline resistance determinant isolated from deep terrestrial subsurface bacteria.
Brown MG; Mitchell EH; Balkwill DL
Antimicrob Agents Chemother; 2008 Dec; 52(12):4518-21. PubMed ID: 18809935
[TBL] [Abstract][Full Text] [Related]
17. High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital.
Curry SR; Marsh JW; Shutt KA; Muto CA; O'Leary MM; Saul MI; Pasculle AW; Harrison LH
Clin Infect Dis; 2009 Feb; 48(4):425-9. PubMed ID: 19140738
[TBL] [Abstract][Full Text] [Related]
18. A new tetracycline efflux gene, tet(40), is located in tandem with tet(O/32/O) in a human gut firmicute bacterium and in metagenomic library clones.
Kazimierczak KA; Rincon MT; Patterson AJ; Martin JC; Young P; Flint HJ; Scott KP
Antimicrob Agents Chemother; 2008 Nov; 52(11):4001-9. PubMed ID: 18779355
[TBL] [Abstract][Full Text] [Related]
19. Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.
O'Connor JR; Galang MA; Sambol SP; Hecht DW; Vedantam G; Gerding DN; Johnson S
Antimicrob Agents Chemother; 2008 Aug; 52(8):2813-7. PubMed ID: 18559647
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of sequences flanking tet(W) resistance genes in multiple species of gut bacteria.
Kazimierczak KA; Flint HJ; Scott KP
Antimicrob Agents Chemother; 2006 Aug; 50(8):2632-9. PubMed ID: 16870752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
